Despite advancements in screening and treatment, marginalized communities remain disproportionately affected by lung cancer due to limited access and various social and structural challenges. Read More ›
People are generally more positive about the perception and frequency of biomarker testing than an earlier survey conducted in 2018, but barriers remain, according to results from a recently released survey. Read More ›
